# Fractional Flow Reserve Guided Immediate Versus Staged Complete Myocardial Revascularization in Patients With ST-segment Elevation Myocardial Infarction With Multivessel Disease (Future Study)

Study · id `cardio:ct-nct05967663` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05967663](<https://clinicaltrials.gov/study/NCT05967663>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05967663

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 840 participants.

## Technical summary

Registry record NCT05967663. Randomized; single masking; primary purpose treatment. Start 2023-11-11 (actual); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 840 participants (planned count; ClinicalTrials.gov record NCT05967663, source copy `cardio:ctgov-nct05967663-2023-12-04`, retrieved 2026-10-26)
- Started: 2023-11-11 (actual) (ClinicalTrials.gov record NCT05967663, source copy `cardio:ctgov-nct05967663-2023-12-04`, retrieved 2026-10-26)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT05967663, source copy `cardio:ctgov-nct05967663-2023-12-04`, retrieved 2026-10-26)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT05967663, source copy `cardio:ctgov-nct05967663-2023-12-04`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05967663, source copy `cardio:ctgov-nct05967663-2023-12-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05967663-2023-12-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Fractional Flow Reserve Guided Immediate Versus Staged Complete Myocardial Revascularization in Patients With ST-segment Elevation Myocardial Infarction With Multivessel Disease (Future Study)
- Condition: ST Elevation Myocardial Infarction
- Intervention (Device): PCI-immediate complete revascularisation
- Intervention (Device): PCI-staged complete revascularisation
- Lead sponsor: RenJi Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)
- Registry lists this organization as the lead sponsor: RenJi Hospital (`cardio:org-renji-hospital`)

## Provenance

Content hash: f2a7df03aa5fafd0feb2fa7509d3f936d1be20686d3e39b51d929ccf789a85da
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
